Maria Antonietta Barbieri

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 37

Top Topics

Metastatic Colorectal Cancer

Chronic Rhinosinusitis

Mild Cognitive Impairment

Top Venues

Pharmaceuticals (Basel, Switzerland)

Journal of neurology

Expert review of clinical pharmacology

This page only lists publications with an associated author ORCID identifier.

Publications

Giuseppe Cicala, Maria Antonietta Barbieri, Giulia Russo, Francesco Salvo, Edoardo Spina
Safety of Dual Orexin Receptor Antagonist Daridorexant: A Disproportionality Analysis of Publicly Available FAERS Data. Pharmaceuticals (Basel, Switzerland) 17 (3) (2024)
Vera Battini, Maria Antonietta Barbieri, Carla Carnovale, Edoardo Spina, Emilio Clementi, Maurizio Sessa
Comparing major and mild cognitive impairment risks in older type-2 diabetic patients: a Danish register-based study on dipeptidyl peptidase-4 inhibitors vs. glucagon-like peptide-1 analogues. Journal of neurology (2024)
Emanuela Elisa Sorbara, Maria Antonietta Barbieri, Giulia Russo, Giuseppe Cicala, Edoardo Spina
Cardiovascular Adverse Drug Reactions of Anti-Calcitonin Gene-Related Peptide Monoclonal Antibodies for Migraine Prevention: An Analysis from the European Spontaneous Adverse Event Reporting System. BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy 38 (2) (2024)
Marianna Cocco, Carla Carnovale, Emilio Clementi, Maria Antonietta Barbieri, Vera Battini, Maurizio Sessa
Exploring the impact of co-exposure timing on drug-drug interactions in signal detection through spontaneous reporting system databases: a scoping review. Expert review of clinical pharmacology (2024)
Marianna Cocco, Carla Carnovale, Emilio Clementi, Maria Antonietta Barbieri, Vera Battini, Maurizio Sessa
Exploring the impact of co-exposure timing on drug-drug interactions in signal detection through spontaneous reporting system databases: a scoping review. Expert review of clinical pharmacology 17 (5-6) (2024)
Vera Battini, Maria Antonietta Barbieri, Carla Carnovale, Edoardo Spina, Emilio Clementi, Maurizio Sessa
Comparing major and mild cognitive impairment risks in older type-2 diabetic patients: a Danish register-based study on dipeptidyl peptidase-4 inhibitors vs. glucagon-like peptide-1 analogues. Journal of neurology 271 (6) (2024)
Vera Battini, Marianna Cocco, Maria Antonietta Barbieri, Greg Powell, Carla Carnovale, Emilio Clementi, Andrew Bate, Maurizio Sessa
Timing Matters: A Machine Learning Method for the Prioritization of Drug-Drug Interactions Through Signal Detection in the FDA Adverse Event Reporting System and Their Relationship with Time of Co-exposure. Drug safety 47 (9) (2024)
Vera Battini, Maria Antonietta Barbieri, Carla Carnovale, Edoardo Spina, Emilio Clementi, Maurizio Sessa
Comparing major and mild cognitive impairment risks in older type-2 diabetic patients: a Danish register-based study on dipeptidyl peptidase-4 inhibitors vs. glucagon-like peptide-1 analogues. Journal of neurology 271 (6) (2024)
Vera Battini, Maria Antonietta Barbieri, Carla Carnovale, Edoardo Spina, Emilio Clementi, Maurizio Sessa
Comparing major and mild cognitive impairment risks in older type-2 diabetic patients: a Danish register-based study on dipeptidyl peptidase-4 inhibitors vs. glucagon-like peptide-1 analogues. Journal of neurology 271 (6) (2024)
Vera Battini, Maria Antonietta Barbieri, Carla Carnovale, Edoardo Spina, Emilio Clementi, Maurizio Sessa
Comparing major and mild cognitive impairment risks in older type-2 diabetic patients: a Danish register-based study on dipeptidyl peptidase-4 inhibitors vs. glucagon-like peptide-1 analogues. Journal of neurology 271 (6) (2024)
Emanuela Elisa Sorbara, Maria Antonietta Barbieri, Giulia Russo, Giuseppe Cicala, Edoardo Spina
Cardiovascular Adverse Drug Reactions of Anti-Calcitonin Gene-Related Peptide Monoclonal Antibodies for Migraine Prevention: An Analysis from the European Spontaneous Adverse Event Reporting System. BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy 38 (2) (2024)
Giuseppe Cicala, Maria Antonietta Barbieri, Giulia Russo, Francesco Salvo, Edoardo Spina
Safety of Dual Orexin Receptor Antagonist Daridorexant: A Disproportionality Analysis of Publicly Available FAERS Data. Pharmaceuticals (Basel, Switzerland) 17 (3) (2024)
Saeed Shakibfar, Kristine Højgaard Allin, Tine Jess, Maria Antonietta Barbieri, Vera Battini, Eva Simoncic, Julien Kirchgesner, Trond Ulven, Maurizio Sessa
Drug Repurposing in Crohn's Disease Using Danish Real-World Data. Pragmatic and observational research 15 (2024)
Emanuela Elisa Sorbara, Maria Antonietta Barbieri, Giulia Russo, Giuseppe Cicala, Edoardo Spina
Cardiovascular Adverse Drug Reactions of Anti-Calcitonin Gene-Related Peptide Monoclonal Antibodies for Migraine Prevention: An Analysis from the European Spontaneous Adverse Event Reporting System. BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy (2024)
Vera Battini, Marianna Cocco, Maria Antonietta Barbieri, Greg Powell, Carla Carnovale, Emilio Clementi, Andrew Bate, Maurizio Sessa
Timing Matters: A Machine Learning Method for the Prioritization of Drug-Drug Interactions Through Signal Detection in the FDA Adverse Event Reporting System and Their Relationship with Time of Co-exposure. Drug safety (2024)
Marianna Cocco, Carla Carnovale, Emilio Clementi, Maria Antonietta Barbieri, Vera Battini, Maurizio Sessa
Exploring the impact of co-exposure timing on drug-drug interactions in signal detection through spontaneous reporting system databases: a scoping review. Expert review of clinical pharmacology 17 (5-6) (2024)
Vera Battini, Marianna Cocco, Maria Antonietta Barbieri, Greg Powell, Carla Carnovale, Emilio Clementi, Andrew Bate, Maurizio Sessa
Timing Matters: A Machine Learning Method for the Prioritization of Drug-Drug Interactions Through Signal Detection in the FDA Adverse Event Reporting System and Their Relationship with Time of Co-exposure. Drug safety 47 (9) (2024)
Vera Battini, Maria Antonietta Barbieri, Carla Carnovale, Edoardo Spina, Emilio Clementi, Maurizio Sessa
Comparing major and mild cognitive impairment risks in older type-2 diabetic patients: a Danish register-based study on dipeptidyl peptidase-4 inhibitors vs. glucagon-like peptide-1 analogues. Journal of neurology 271 (6) (2024)
Marianna Cocco, Carla Carnovale, Emilio Clementi, Maria Antonietta Barbieri, Vera Battini, Maurizio Sessa
Exploring the impact of co-exposure timing on drug-drug interactions in signal detection through spontaneous reporting system databases: a scoping review. Expert review of clinical pharmacology (2024)
Saeed Shakibfar, Kristine Højgaard Allin, Tine Jess, Maria Antonietta Barbieri, Vera Battini, Eva Simoncic, Julien Kirchgesner, Trond Ulven, Maurizio Sessa
Drug Repurposing in Crohn's Disease Using Danish Real-World Data. Pragmatic and observational research 15 (2024)
Vera Battini, Marianna Cocco, Maria Antonietta Barbieri, Greg Powell, Carla Carnovale, Emilio Clementi, Andrew Bate, Maurizio Sessa
Timing Matters: A Machine Learning Method for the Prioritization of Drug-Drug Interactions Through Signal Detection in the FDA Adverse Event Reporting System and Their Relationship with Time of Co-exposure. Drug safety 47 (9) (2024)
Giuseppe Cicala, Maria Antonietta Barbieri, Giulia Russo, Francesco Salvo, Edoardo Spina
Safety of Dual Orexin Receptor Antagonist Daridorexant: A Disproportionality Analysis of Publicly Available FAERS Data. Pharmaceuticals (Basel, Switzerland) 17 (3) (2024)
Maria Antonietta Barbieri, Emanuela Elisa Sorbara, Giulia Russo, Giuseppe Cicala, Tindara Franchina, Mariacarmela Santarpia, Nicola Silvestris, Edoardo Spina
Neuropsychiatric Adverse Drug Reactions with Tyrosine Kinase Inhibitors in Gastrointestinal Stromal Tumors: An Analysis from the European Spontaneous Adverse Event Reporting System. Cancers 15 (6) (2023)
Cosimo Galletti, Maria Antonietta Barbieri, Francesco Ciodaro, Francesco Freni, Francesco Galletti, Edoardo Spina, Bruno Galletti
Effectiveness and Safety Profile of Dupilumab in Chronic Rhinosinusitis with Nasal Polyps: Real-Life Data in Tertiary Care. Pharmaceuticals (Basel, Switzerland) 16 (4) (2023)
Giulia Russo, Maria Antonietta Barbieri, Emanuela Elisa Sorbara, Giuseppe Cicala, Tindara Franchina, Mariacarmela Santarpia, Nicola Silvestris, Edoardo Spina
Renal Disorders with Oral Tyrosine Kinase Inhibitors in Metastatic Colorectal Cancer: An Analysis from the FDA Adverse Event Reporting System Database. Biomedicines 11 (8) (2023)
Cosimo Galletti, Maria Antonietta Barbieri, Francesco Ciodaro, Francesco Freni, Francesco Galletti, Edoardo Spina, Bruno Galletti
Effectiveness and Safety Profile of Dupilumab in Chronic Rhinosinusitis with Nasal Polyps: Real-Life Data in Tertiary Care. Pharmaceuticals (Basel, Switzerland) 16 (4) (2023)
Maria Antonietta Barbieri, Natasha Irrera, Irma Convertino
Drug Safety and Relevant Issues in the Real-World. Pharmaceuticals (Basel, Switzerland) 16 (12) (2023)
Maria Antonietta Barbieri, Natasha Irrera, Irma Convertino
Drug Safety and Relevant Issues in the Real-World. Pharmaceuticals (Basel, Switzerland) 16 (12) (2023)
Maria Antonietta Barbieri, Emanuela Elisa Sorbara, Giulia Russo, Giuseppe Cicala, Tindara Franchina, Mariacarmela Santarpia, Nicola Silvestris, Edoardo Spina
Neuropsychiatric Adverse Drug Reactions with Tyrosine Kinase Inhibitors in Gastrointestinal Stromal Tumors: An Analysis from the European Spontaneous Adverse Event Reporting System. Cancers 15 (6) (2023)
Cosimo Galletti, Maria Antonietta Barbieri, Francesco Ciodaro, Francesco Freni, Francesco Galletti, Edoardo Spina, Bruno Galletti
Effectiveness and Safety Profile of Dupilumab in Chronic Rhinosinusitis with Nasal Polyps: Real-Life Data in Tertiary Care. Pharmaceuticals (Basel, Switzerland) 16 (4) (2023)
Cosimo Galletti, Maria Antonietta Barbieri, Francesco Ciodaro, Francesco Freni, Francesco Galletti, Edoardo Spina, Bruno Galletti
Effectiveness and Safety Profile of Dupilumab in Chronic Rhinosinusitis with Nasal Polyps: Real-Life Data in Tertiary Care. Pharmaceuticals (Basel, Switzerland) 16 (4) (2023)
Maria Antonietta Barbieri, Anna Viola, Giuseppe Cicala, Edoardo Spina, Walter Fries
Effectiveness and Safety Profiles of Biological Therapies in Inflammatory Bowel Disease: Real Life Data from an Active Pharmacovigilance Project. Biomedicines 10 (12) (2022)
Maria Antonietta Barbieri, Anna Viola, Giuseppe Cicala, Edoardo Spina, Walter Fries
Effectiveness and Safety Profiles of Biological Therapies in Inflammatory Bowel Disease: Real Life Data from an Active Pharmacovigilance Project. Biomedicines 10 (12) (2022)
Maria Antonietta Barbieri, Emanuela Elisa Sorbara, Giuseppe Cicala, Vincenza Santoro, Paola Maria Cutroneo, Tindara Franchina, Edoardo Spina
Adverse Drug Reactions with HER2-Positive Breast Cancer Treatment: An Analysis from the Italian Pharmacovigilance Database. Drugs - real world outcomes (2021)
Maria Antonietta Barbieri, Paola Maria Cutroneo, Chiara Baratelli, Giuseppe Cicala, Alessandro Battaglia, Vincenza Santoro, Giuseppe Andò, Edoardo Spina
Adverse drug reactions with oral anticoagulants: data from sicilian spontaneous reporting system database. Journal of clinical pharmacy and therapeutics 46 (4) (2021)
Maria Antonietta Barbieri, Giuseppe Cicala, Paola Maria Cutroneo, Elisabetta Gerratana, Caterina Palleria, Caterina De Sarro, Ada Vero, Luigi Iannone, Antonia Manti, Emilio Russo, Giovambattista De Sarro, Fabiola Atzeni, Edoardo Spina
Safety Profile of Biologics Used in Rheumatology: An Italian Prospective Pharmacovigilance Study. Journal of clinical medicine 9 (4) (2020)
Edoardo Spina, Maria Antonietta Barbieri, Giuseppe Cicala, Jose de Leon
Clinically Relevant Interactions between Atypical Antipsychotics and Anti-Infective Agents. Pharmaceuticals (Basel, Switzerland) 13 (12) (2020)